Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Apotex has paid Sanofi and Bristol-Myers Squibb Company an amount of $442,209,362 to satisfy the damages ruling of the Plavix (clopidogrel bisulfate) patent infringement case.
Subscribe to our email newsletter
The payment represents the final phase of the Plavix patent litigation between the companies and Apotex, which was initiated in 21March 2002.
Apotex also paid $1,258,682 in interest on the judgement given by US Court of Appeals for the Federal Circuit in October 2011 and another $900,000 in costs in addition to the damages award.
Sanofi and Bristol said they are pleased that Apotex has made reparation of the harm caused by the launch of a generic clopidogrel bisulfate in 2006.